{"slideshow_credits": null, "snippet": "Companies can drop prices and still make money, says the chief executive of GlaxoSmithKline....", "abstract": null, "section_name": "Opinion", "print_page": null, "document_type": "article", "byline": {"person": [{"firstname": "Vikas", "role": "reported", "lastname": "BAJAJ", "rank": 1, "organization": ""}], "original": "By VIKAS BAJAJ"}, "web_url": "http://www.nytimes.com/2016/10/21/opinion/the-pharma-ceo-who-wants-to-lower-drug-prices.html", "lead_paragraph": "Companies can drop prices and still make money, says the chief executive of GlaxoSmithKline.", "headline": {"main": "The Pharma C.E.O. Who Wants to Lower Drug Prices", "content_kicker": "Taking Note", "kicker": "Taking Note"}, "_id": "580a4a6495d0e022439c4868", "word_count": "700", "multimedia": [{"height": 126, "url": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-articleLarge.jpg", "legacy": {"xlarge": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-10-21T17:03:25+0000", "source": "The New York Times", "news_desk": "Editorial", "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "1"}, {"name": "subject", "value": "Health Insurance and Managed Care", "is_major": "N", "rank": "2"}], "blog": [], "subsection_name": null, "type_of_material": "Editorial"}